High-content abamectin emulsifiable concentrate

US12502373B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-12502373-B2
Application numberUS-202117517765-A
CountryUS
Kind codeB2
Filing dateNov 3, 2021
Priority dateNov 3, 2021
Publication dateDec 23, 2025
Grant dateDec 23, 2025

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

An emulsifiable concentrate comprising a high content of abamectin is provided. The concentrate includes an amide solvent of formula (I) and an alkyl lactate of formula (II): wherein R 1 is C 5 -C 19 alkyl and R 2 is methyl, ethyl, propyl, butyl or a mixture thereof; wherein R 3 is C 1 -C 16 alkyl. The concentrate optionally includes a surfactant. The concentrate exhibits very good low temperature stability and dilution stability. A method for preparing the concentrate; and an emulsion that can be obtained by mixing water, abamectin, the amide of formula (I) and the alkyl lactate of formula (II), is also provided.

First claim

Opening claim text (preview).

The invention claimed is: 1 . An emulsifiable concentrate, comprising: (1) abamectin in an amount of 5 wt. %-20 wt. %, based on the total weight of the concentrate; (2) an amide selected from the group consisting of N,N-dimethyl capramide, N,N-dimethyl octanamide, and N,N-dimethyl dodecylamide in an amount of 20 wt. %-60 wt. %, based on the total weight of the concentrate; and (3) an optional surfactant. 2 . The concentrate according to claim 1 , further including an alkyl lactate of formula (II): wherein R 3 is C 1 -C 16 alkyl; and wherein the alkyl lactate of formula (II) is present in an amount of 5 wt. %-55 wt. %, based on the total weight of the concentrate. 3 . The concentrate according to claim 2 , wherein R 3 in formula (II) is C 1 -C 8 alkyl. 4 . The concentrate according to claim 1 , wherein the optional surfactant is present in an amount of 1 wt. %-30 wt. %, based on the total weight of the concentrate. 5 . The concentrate according to claim 4 , wherein the optional surfactant is present in an amount of 5 wt. %-20 wt. %, based on the total weight of the concentrate. 6 . The concentrate according to claim 1 , wherein the optional surfactant is present, and the optional surfactant is an anionic surfactant selected from the group consisting of: alkali metals, alkaline earth metals or ammonium salts of sulfonic acid, sulfuric acid, phosphoric acid, and carboxylic acid, and mixtures thereof. 7 . The concentrate according to claim 1 , wherein the optional surfactant is present, and the optional surfactant is a nonionic surfactant selected from the group consisting of: alkoxylates, N-substituted fatty acid amides, amine oxides, esters, glycosyl surfactants, polymeric surfactants and mixtures thereof. 8 . The concentrate according to claim 1 , wherein the optional surfactant is present, and the optional surfactant is a cationic surfactant selected from the group consisting of: quaternary ammonium compounds having 1 or 2 hydrophobic groups, and salts of primary amines. 9 . The concentrate according to claim 1 , wherein the optional surfactant is present, and the optional surfactant is selected from the group consisting of: amphoteric surfactants, block polymers, and polyelectrolytes. 10 . A method for preparing the concentrate according to claim 1 by mixing the abamectin, the amide, and the optional surfactant. 11 . An emulsion obtained by mixing water with the concentrate according to claim 1 . 12 . An emulsifiable concentrate, comprising: (1) abamectin in an amount of 5 wt. %-20 wt. %, based on the total weight of the concentrate; (2) an alkyl lactate selected from the group consisting of: methyl lactate, ethyl lactate, and butyl lactate in an amount of 25 wt. %-40 wt. %, based on the total weight of the concentrate; and (3) an optional surfactant. 13 . The concentrate according to claim 1 , wherein the abamectin is present in an amount of 10 wt. %-20 wt. %, based on the total weight of the concentrate. 14 . The concentrate of claim 2 , wherein the alkyl lactate of formula (II) is present in an amount of 10 wt. %-50 wt. %, based on the total weight of the concentrate. 15 . The concentrate of claim 12 , wherein the abamectin is present in an amount of 10 wt. %-20 wt. %, based on the total weight of the concentrate.

Assignees

Inventors

Classifications

  • Emulsions {; Emulsion preconcentrates; Micelles (composition of emulsions A61K47/00)} · CPC title

  • Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids · CPC title

  • A61K31/351Primary

    not condensed with another ring · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US12502373B2 cover?
An emulsifiable concentrate comprising a high content of abamectin is provided. The concentrate includes an amide solvent of formula (I) and an alkyl lactate of formula (II): wherein R 1 is C 5 -C 19 alkyl and R 2 is methyl, ethyl, propyl, butyl or a mixture thereof; …
Who is the assignee on this patent?
Rotam Agrochem Int Co Ltd, Albaugh Llc
What technology area does this patent fall under?
Primary CPC classification A61K31/351. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Dec 23 2025 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).